Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/14/1993 | CA2133076A1 Imidazole, triazole and tetrazole derivatives |
10/14/1993 | CA2132981A1 Phenol and pyridinol derivatives as lusitropic agents |
10/14/1993 | CA2132849A1 Bridged bis-aryl carbinol derivatives, compositions and methods of use |
10/14/1993 | CA2132848A1 Unabridged bis-aryl carbinol derivatives, compositions and methods of use |
10/14/1993 | CA2130992A1 Method for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizing sphingosine-1-phosphate and its derivatives |
10/14/1993 | CA2130937A1 Pharmaceutically active bicyclic-heterocyclic amines |
10/14/1993 | CA2129962A1 Therapeutic use of phenothiazine derivatives |
10/14/1993 | CA2126341A1 Lipid-a analogs: new monosaccharide and dissaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities |
10/14/1993 | CA2110176A1 Topical preparation for healing wounds of the skin |
10/14/1993 | CA2093771A1 Piperazine derivatives |
10/13/1993 | EP0565495A1 Pharmaceutical composition containing glycyrrhetinic acid and phenanthridine alkaloids |
10/13/1993 | EP0565412A1 Compositions containing 5-iodouracil derivatives for the treatment of hepatitis B infections |
10/13/1993 | EP0565396A1 1-(2-arylsulfonylamino)-1-oxoethyl)-piperidine derivatives, their preparation and use in therapy |
10/13/1993 | EP0565377A1 Therapeutic agents for use in the treatment of parkinson's disease |
10/13/1993 | EP0565317A1 (2-(2-hydroxy-2 phenylethylamino)ethoxy) phenyl derivatives, processes and intermediates for their preparation, pharmaceutical compositions containing them and their use as Beta-3-adrenoceptor agonists |
10/13/1993 | EP0565301A1 Prolonged-release liquid type of pharmaceutical preparation |
10/13/1993 | EP0565296A1 Use of melatonin for the manufacture of a medicament for the treatment of benign prostatic hyperplasia |
10/13/1993 | EP0565274A1 5-Ht1A agonists for improving primary memory and/or learning |
10/13/1993 | EP0565241A1 Oligosaccharides |
10/13/1993 | EP0565210A2 Vehicles for oral adminstration of pharmaceutically active acide labile substances |
10/13/1993 | EP0565185A1 Quinoline derivatives as leukotriene antagonists |
10/13/1993 | EP0565146A2 Use of a thioester for preparing pharmaceutical compositions for the treatment of ischemia and reperfusion syndromes |
10/13/1993 | EP0565135A1 Known and selected novel arylmethylenyl derivatives of imidazolidinones useful as antiallergy agents and antiinflammatory agents |
10/13/1993 | EP0565132A2 Benzoheterocyclic compounds |
10/13/1993 | EP0565059A1 Indole derivative |
10/13/1993 | EP0564960A1 Imidazopyridines as angiotensin II antagonists |
10/13/1993 | EP0564924A2 2-Oxoethyl derivatives as immunosuppressants |
10/13/1993 | EP0564835A2 2,2-Disubstituted cephem sulphones |
10/13/1993 | EP0564805A1 (4-benzylphthalazin-1(2H)-on-2-yl)aminocarboxylic acids having antiallergic/antihistaminic activity and process for their production |
10/13/1993 | EP0564804A1 Improved high protein liquid nutrition for patients with elevated wound healing requirements |
10/13/1993 | EP0564803A1 Use of aminoacids for improving the quality of sleep and treating sleep disorders |
10/13/1993 | EP0564788A2 Sulfonylbenzyl substituted imidazopyridines as AII-antagonists |
10/13/1993 | EP0564722A1 Lathyrogenic agents and apparatus for the treatment of fibrotic lesions |
10/13/1993 | EP0564658A1 2-(2,3-dicarboxycyclopropyl)glycine and method for producing the same. |
10/13/1993 | EP0564656A1 Cosmetic composition and emulsion composition |
10/13/1993 | EP0564592A1 Liver enriched transcription factor |
10/13/1993 | EP0564561A1 Peptides ketoamides, ketoacids, and ketoesters |
10/13/1993 | EP0564552A1 Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
10/13/1993 | EP0564520A1 Use of certain glutarimide derivatives in the treatment of depression and mania |
10/13/1993 | EP0564502A1 Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
10/13/1993 | EP0564479A1 Thiangazole, its preparation, compositions and use thereof |
10/13/1993 | EP0560937A4 Pharmaceutical compositions |
10/13/1993 | EP0458886B1 Agents for diagnosing and treating melanomas, aromatic halogenated derivatives usable as such agents and their preparation |
10/13/1993 | EP0458823B1 A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines |
10/13/1993 | EP0431076B1 Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers |
10/13/1993 | EP0396748B1 Agent for treating ischemic brain trouble |
10/13/1993 | EP0353267B1 Emulsion for parenteral administration |
10/13/1993 | CN1077200A Process |
10/13/1993 | CN1077199A Therapeutic nucleosides |
10/13/1993 | CN1077198A Anti-proliferative and anti-inflammatory compounds:5-or 6-deoxy hexose monosacchardies having a saturated nitrogen containing heterocycle at the 5-or 6-position bound through the nitrogen atom |
10/13/1993 | CN1077195A Sulphonylbenzyl-substituted imidazopyridines |
10/13/1993 | CN1077192A 2-oxoquinoline derivatives |
10/13/1993 | CN1077115A Physiologic multi-salt liquid |
10/13/1993 | CN1022416C Sialosyl glyceride and process for producing same |
10/13/1993 | CN1022414C Process for preparing cyclic buttane derivatives |
10/13/1993 | CN1022407C Phenoxyalkylcarboxylic acid derivatives and process for their preparation |
10/12/1993 | US5252753 Reacting phenyl tetrazole with Grignard reagant; angiotensin receptor antagonist |
10/12/1993 | US5252749 Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them |
10/12/1993 | US5252732 D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity |
10/12/1993 | US5252728 Process for obtaining polymers with antiviral activity |
10/12/1993 | US5252722 5-O-α-D-glucopyranosyl-L-ascorbic acid |
10/12/1993 | US5252720 Metal complexes of water soluble texaphyrins |
10/12/1993 | US5252707 Inositol derivative and method for preparing same |
10/12/1993 | US5252705 Peptide derivatives |
10/12/1993 | US5252673 Reaction product of divinyl ether-maleic anhydride copolymer, an aminoacid and mitomycin C; antitumor agents, anticarcino-genic |
10/12/1993 | US5252608 Preventing the abnormal deposition of collagen by administering a halogenated allyl amines |
10/12/1993 | US5252607 Administering metoclopramide |
10/12/1993 | US5252606 In synergistic mixture with quaternary ammonium chloride, tert-amyl phenol, citric acid, isopropanol and water |
10/12/1993 | US5252605 Promotion of wound-healing with 15-keto-prostaglandin compounds |
10/12/1993 | US5252604 Compositions of retinoic acids and tocopherol for prevention of dermatitis |
10/12/1993 | US5252603 Immunosuppressive analogues and derivatives of succinylacetone |
10/12/1993 | US5252602 Effects of misoprostol on allergic responses |
10/12/1993 | US5252601 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors |
10/12/1993 | US5252600 Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof |
10/12/1993 | US5252595 Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenylamino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines |
10/12/1993 | US5252593 Pyrazole containing benzofuran derivatives and pharmaceutical compositions |
10/12/1993 | US5252592 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity |
10/12/1993 | US5252591 Renin inhibitors |
10/12/1993 | US5252589 Benzocycloheptene derivative and process for preparation thereof |
10/12/1993 | US5252588 Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation |
10/12/1993 | US5252584 Antagonist for treating nervous system disorders |
10/12/1993 | US5252583 Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension |
10/12/1993 | US5252581 Substituted aminothienopyridines, pharmaceutical composition and use |
10/12/1993 | US5252580 Indole derivatives and anti-ulcer compositions thereof |
10/12/1993 | US5252579 Macrocyclic immunomodulators |
10/12/1993 | US5252578 3-aminochroman compounds |
10/12/1993 | US5252577 Applying a barbiturates |
10/12/1993 | US5252574 Hypotensive agents, vision disorder |
10/12/1993 | US5252571 Antidiabetic agents |
10/12/1993 | US5252568 Treatment of low pressure glaucoma and ischemic retinal degeneration with loxapine |
10/12/1993 | US5252567 Cardiovascular disorders, sino-atrial node effects |
10/12/1993 | US5252564 Method to decrease cortisol secretion by feeding melengesterol acetate |
10/12/1993 | US5252563 5,6,7,8-tetrahydro-imidazo[1,2-a]pyrimidine compounds for treatment of neurotoxic injury |
10/12/1993 | US5252562 Lipoxygenase inhibitor |
10/12/1993 | US5252561 Preparation for the controlled release of active substances which are suitable as a therapeutics or for improving growth and feed utilization in ruminants |
10/12/1993 | US5252479 Safe vector for gene therapy |
10/12/1993 | US5252344 Hardening agent for affected tissues of the digestive system |
10/12/1993 | US5252341 Tablets and granulates containing mesna as active substance |
10/12/1993 | US5252339 Pharmaceutical compositions containing orally absorbable glycosamimoglycans |
10/12/1993 | US5252338 Therapy delayed |